Medikit Co.,Ltd. (TYO:7749)
2,985.00
-10.00 (-0.33%)
Mar 10, 2026, 10:33 AM JST
Medikit Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 20,145 | 21,559 | 23,611 | 27,592 | 28,118 | 27,491 | Upgrade
|
| Cash & Short-Term Investments | 20,145 | 21,559 | 23,611 | 27,592 | 28,118 | 27,491 | Upgrade
|
| Cash Growth | -0.63% | -8.69% | -14.43% | -1.87% | 2.28% | 2.46% | Upgrade
|
| Receivables | 5,828 | 5,059 | 5,285 | 5,691 | 5,004 | 4,874 | Upgrade
|
| Inventory | 5,106 | 4,567 | 3,877 | 3,281 | 3,626 | 3,699 | Upgrade
|
| Restricted Cash | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | Upgrade
|
| Other Current Assets | 197 | 558 | 218 | 112 | 293 | 60 | Upgrade
|
| Total Current Assets | 32,776 | 33,243 | 34,491 | 38,176 | 38,541 | 37,624 | Upgrade
|
| Property, Plant & Equipment | 14,485 | 14,447 | 11,474 | 10,438 | 10,834 | 10,052 | Upgrade
|
| Long-Term Investments | 1,575 | 1,237 | 1,248 | 1,077 | 1,136 | 1,180 | Upgrade
|
| Goodwill | 1,957 | 2,120 | 2,337 | 1,935 | - | - | Upgrade
|
| Other Intangible Assets | 1,074 | 1,163 | 1,138 | 1,157 | 126 | 246 | Upgrade
|
| Long-Term Deferred Tax Assets | 80 | 259 | 310 | 402 | 419 | 816 | Upgrade
|
| Other Long-Term Assets | - | 1 | 1 | 1 | 1 | 2 | Upgrade
|
| Total Assets | 51,947 | 52,470 | 50,999 | 53,186 | 51,057 | 49,920 | Upgrade
|
| Accounts Payable | 3,122 | 3,469 | 3,180 | 2,545 | 2,575 | 2,276 | Upgrade
|
| Accrued Expenses | 211 | 423 | 412 | 413 | 397 | 410 | Upgrade
|
| Current Income Taxes Payable | 759 | 866 | 897 | 765 | 604 | 451 | Upgrade
|
| Other Current Liabilities | 1,094 | 1,401 | 1,229 | 950 | 838 | 1,017 | Upgrade
|
| Total Current Liabilities | 5,186 | 6,159 | 5,718 | 4,673 | 4,414 | 4,154 | Upgrade
|
| Pension & Post-Retirement Benefits | - | - | - | 86 | 84 | 140 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 326 | 340 | 336 | 330 | - | - | Upgrade
|
| Other Long-Term Liabilities | 823 | 816 | 817 | 806 | 788 | 1,991 | Upgrade
|
| Total Liabilities | 6,342 | 7,315 | 6,871 | 5,895 | 5,286 | 6,285 | Upgrade
|
| Common Stock | 1,241 | 1,241 | 1,241 | 1,241 | 1,241 | 1,241 | Upgrade
|
| Additional Paid-In Capital | 8,385 | 8,378 | 8,432 | 10,384 | 10,378 | 10,378 | Upgrade
|
| Retained Earnings | 38,188 | 37,340 | 39,826 | 38,519 | 37,165 | 35,012 | Upgrade
|
| Treasury Stock | -2,929 | -2,545 | -6,046 | -3,243 | -3,256 | -3,190 | Upgrade
|
| Comprehensive Income & Other | 720 | 741 | 675 | 390 | 243 | 194 | Upgrade
|
| Shareholders' Equity | 45,605 | 45,155 | 44,128 | 47,291 | 45,771 | 43,635 | Upgrade
|
| Total Liabilities & Equity | 51,947 | 52,470 | 50,999 | 53,186 | 51,057 | 49,920 | Upgrade
|
| Net Cash (Debt) | 20,138 | 21,559 | 23,611 | 27,592 | 28,118 | 27,491 | Upgrade
|
| Net Cash Growth | -0.66% | -8.69% | -14.43% | -1.87% | 2.28% | 2.46% | Upgrade
|
| Net Cash Per Share | 1379.13 | 1463.41 | 1445.78 | 1643.95 | 1673.59 | 1626.98 | Upgrade
|
| Filing Date Shares Outstanding | 14.54 | 14.62 | 14.8 | 16.79 | 16.78 | 16.81 | Upgrade
|
| Total Common Shares Outstanding | 14.54 | 14.62 | 14.8 | 16.79 | 16.78 | 16.81 | Upgrade
|
| Working Capital | 27,590 | 27,084 | 28,773 | 33,503 | 34,127 | 33,470 | Upgrade
|
| Book Value Per Share | 3136.67 | 3089.51 | 2982.53 | 2817.14 | 2727.96 | 2596.51 | Upgrade
|
| Tangible Book Value | 42,574 | 41,872 | 40,653 | 44,199 | 45,645 | 43,389 | Upgrade
|
| Tangible Book Value Per Share | 2928.20 | 2864.88 | 2747.66 | 2632.95 | 2720.45 | 2581.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.